Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?

COVID-19: Coverage of the pandemic from MPR News

The latest news, resources, guides and tips to help you stay up to date on the coronavirus pandemic.

Stay up-to-date Daily data and trends | Sign up for weekly analysis of the latest data

Guides and tips Booster FAQ | Masks | Submit your questions | Tips for parents | Mental health resources

Guide our coverage: Pandemic reflections survey

Osterholm: 'Stay current' on upcoming COVID booster shots

Osterholm: 'Stay current' on upcoming COVID booster shots

Upgraded COVID-19 vaccines are on the way. On Wednesday, the Food and Drug Administration approved new, reformulated versions of the Moderna and Pfizer vaccines. Michael Osterholm joins MPR News host Cathy Wurzer to share what that means for our immunity against new and future strains of the virus.
by Cathy Wurzer, Aron Woldeslassie, Matt Mikus and Gretchen Brown

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
U.S. clears updated COVID boosters targeting newest variants

U.S. clears updated COVID boosters targeting newest variants

U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain. The move on Wednesday by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. 
by The Associated Press

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
Life expectancy in the U.S. continues to drop, driven by COVID-19

Life expectancy in the U.S. continues to drop, driven by COVID-19

Americans' life expectancy dropped for the second year in a row and is now the lowest it's been since the 1920s. COVID-19 is driving the downward trend, according to CDC data.
by Jane Greenhalgh and Selena Simmons-Duffin

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
COVID trends are mostly flat, but proceed with caution

COVID trends are mostly flat, but proceed with caution

With tens of thousands of Minnesotans getting together daily at the State Fair, and millions of students returning to school in the near future, we wish that the data showed vanishing COVID-19 risks. But, as the graphs and maps below continue to show, that is not the case.
by Elisabeth Gawthrop and Craig Helmstetter

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!
Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
by Pien Huang and Will Stone

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!